Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Intraperitoneal photodynamic therapy.

Cengel KA, Glatstein E, Hahn SM.

Cancer Treat Res. 2007;134:493-514. Review.

PMID:
17633077
2.

A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis.

Hahn SM, Fraker DL, Mick R, Metz J, Busch TM, Smith D, Zhu T, Rodriguez C, Dimofte A, Spitz F, Putt M, Rubin SC, Menon C, Wang HW, Shin D, Yodh A, Glatstein E.

Clin Cancer Res. 2006 Apr 15;12(8):2517-25.

3.

Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors.

Hendren SK, Hahn SM, Spitz FR, Bauer TW, Rubin SC, Zhu T, Glatstein E, Fraker DL.

Ann Surg Oncol. 2001 Jan-Feb;8(1):65-71.

PMID:
11206227
4.

Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis.

Wilson JJ, Jones H, Burock M, Smith D, Fraker DL, Metz J, Glatstein E, Hahn SM.

Int J Oncol. 2004 Mar;24(3):711-7.

PMID:
14767557
5.

Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A preclinical study.

Azaïs H, Schmitt C, Tardivel M, Kerdraon O, Stallivieri A, Frochot C, Betrouni N, Collinet P, Mordon S.

Photodiagnosis Photodyn Ther. 2016 Mar;13:130-8. doi: 10.1016/j.pdpdt.2015.07.005. Epub 2015 Jul 19.

PMID:
26200606
6.
7.

Immunotherapy: a way to improve the therapeutic outcome of photodynamic therapy?

Kwitniewski M, Juzeniene A, Glosnicka R, Moan J.

Photochem Photobiol Sci. 2008 Sep;7(9):1011-7. doi: 10.1039/b806710d. Epub 2008 Jul 21. Review.

PMID:
18754046
8.

Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy.

Wang HW, Zhu TC, Putt ME, Solonenko M, Metz J, Dimofte A, Miles J, Fraker DL, Glatstein E, Hahn SM, Yodh AG.

J Biomed Opt. 2005 Jan-Feb;10(1):14004.

PMID:
15847585
9.

Use of photodynamic therapy for the management of pleural malignancies.

Pass HI, Donington JS.

Semin Surg Oncol. 1995 Sep-Oct;11(5):360-7. Review.

PMID:
7569558
10.
11.

Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy.

Hahn SM, Putt ME, Metz J, Shin DB, Rickter E, Menon C, Smith D, Glatstein E, Fraker DL, Busch TM.

Clin Cancer Res. 2006 Sep 15;12(18):5464-70.

12.

Tailor-made approach to photodynamic therapy in the treatment of cancer based on Bcl-2 photodamage.

Usuda J, Hirata T, Ichinose S, Ishizumi T, Inoue T, Ohtani K, Maehara S, Yamada M, Tsutsui H, Okunaka T, Kato H, Ikeda N.

Int J Oncol. 2008 Oct;33(4):689-96.

PMID:
18813781
13.

Photodynamic therapy of cerebral glioma - a review. Part II - clinical studies.

Stylli SS, Kaye AH.

J Clin Neurosci. 2006 Aug;13(7):709-17. Epub 2006 Mar 29. Review.

PMID:
16567094
14.

Effect of photosensitizer dose on fluence rate responses to photodynamic therapy.

Wang HW, Rickter E, Yuan M, Wileyto EP, Glatstein E, Yodh A, Busch TM.

Photochem Photobiol. 2007 Sep-Oct;83(5):1040-8.

PMID:
17880498
15.

A review of photodynamic therapy (PDT) for the treatment of acne vulgaris.

Riddle CC, Terrell SN, Menser MB, Aires DJ, Schweiger ES.

J Drugs Dermatol. 2009 Nov;8(11):1010-9. Review.

PMID:
19894368
16.

Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment.

Korbelik M, Cecic I.

J Photochem Photobiol B. 1998 Jul 10;44(2):151-8.

PMID:
9757597
17.

Vascularity and uptake of photosensitizer in small human tumor nodules: implications for intraperitoneal photodynamic therapy.

Menon C, Kutney SN, Lehr SC, Hendren SK, Busch TM, Hahn SM, Fraker DL.

Clin Cancer Res. 2001 Dec;7(12):3904-11.

18.

Combination sonodynamic therapy with immunoadjuvant may be a promising new modality for cancer treatment.

Ma X, Pan H, Yi J.

Med Hypotheses. 2009 Apr;72(4):418-20. doi: 10.1016/j.mehy.2008.10.024. Epub 2009 Jan 6.

PMID:
19128891
19.

Bis(3,5-diiodo-2,4,6-trihydroxyphenyl)squaraine: a novel candidate in photodynamic therapy for skin cancer models in vivo.

Gayathri Devi D, Cibin TR, Ramaiah D, Abraham A.

J Photochem Photobiol B. 2008 Sep 18;92(3):153-9. doi: 10.1016/j.jphotobiol.2008.06.002. Epub 2008 Jun 24.

PMID:
18653354
20.

Preclinical evaluation of motexafin lutetium-mediated intraperitoneal photodynamic therapy in a canine model.

Griffin GM, Zhu T, Solonenko M, Del Piero F, Kapakin A, Busch TM, Yodh A, Polin G, Bauer T, Fraker D, Hahn SM.

Clin Cancer Res. 2001 Feb;7(2):374-81.

Supplemental Content

Support Center